日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Recycling Collagen Receptor uPARAP Is a Unique Mediator of Stromal Drug Delivery to Carcinoma Cells.

回收胶原蛋白受体 uPARAP 是基质药物递送至癌细胞的独特介质。

Nørregaard Kirstine S, Larsen Ida M E, Jürgensen Henrik J, Blomquist Michaela Hansen, Çakilkaya Pinar, Metrangolo Virginia, Perlado Alba Martinez, Krigslund Oliver, Gårdsvoll Henrik, Poulsen Thomas T, Mumberg Dominik, Santoni-Rugiu Eric, Engelholm Lars H, Behrendt Niels

Histological fidelity and microenvironmental kinome signatures of metastatic patient-derived organoids

转移性患者来源类器官的组织学保真度和微环境激酶组特征

Leitão-Castro, Joana; Lopresti, Alexia Melanie; Zornhagen, Kamilla Westarp; Albrechtsen, Reidar; Camacho-Roda, Juan; Ravn, Mille Bylov; Martinez, Alejandro Gutierrez; Perez, Luis Arnes; Santoni-Rugiu, Eric; Højgaard, Martin; Rohrberg, Kristoffer Staal; Lassen, Ulrik; Erler, Janine Terra

Targeting uPARAP with an Antibody-Drug Conjugate Exhibits Efficacy against Mesothelioma and Synergizes with Cisplatin

利用抗体-药物偶联物靶向uPARAP可有效治疗间皮瘤,并与顺铂产生协同作用

Çakılkaya, Pınar; Egeland Larsen, Ida Marie; Jiang, Qun; Sandal Nørregaard, Kirstine; Gårdsvoll, Henrik; Zhang, Jingli; Jürgensen, Henrik Jessen; Hansen Blomquist, Michaela; Martinez Perlado, Alba; Krigslund, Oliver; Santoni-Rugiu, Eric; Engelholm, Lars Henning; Hassan, Raffit; Behrendt, Niels

Rationale and Design of the MIA Trial: A Proof-of-Concept Study of Minimally Invasive Autopsy in an Infectious Cause of Death in a Scandinavian ICU Setting

MIA试验的理论基础和设计:一项在北欧ICU环境下针对感染性死亡原因开展的微创尸检概念验证研究

Helgesen, Fridtjof Gjerdrum; Toft, Birgitte Grønkær; Donato, Camilla Musaeus; Pedersen, Ulf Gøttrup; Hildebrandt, Thomas; Nielsen, Xiaohui Chen; Santoni-Rugiu, Eric; Willemoe, Gro Linno; Wiese, Lothar; Nielsen, Henning Bay

Deep Learning-Based Tumor Cell Classification in Lung Adenocarcinoma With a Case-by-Case Human-in-the-Loop Approach

基于深度学习的肺腺癌肿瘤细胞分类:一种逐例人机协作方法

Stampe, Martin; Klausen, Pia; Christiansen, Ida Skovgaard; Rift, Charlotte Vestrup; Koffeldt, Peter Rindom; Hartvig, Rasmus; Santoni-Rugiu, Eric; Jensen, Thomas H L

Correlation of TP53 Mutations With p53 Expression and Ki-67 Index in Pulmonary Large Cell Neuroendocrine Carcinomas

TP53突变与肺大细胞神经内分泌癌中p53表达和Ki-67指数的相关性

Stampe, Martin; Smidt, Jonas; Melchior, Linea; Grauslund, Morten; Federspiel, Birgitte; Santoni-Rugiu, Eric; Jensen, Thomas Hartvig Lindkær

Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC

完善选择晚期ALK重排非小细胞肺癌患者一线治疗方案的真实世界标准

Urbanska, Edyta Maria; Koffeldt, Peter Rindom; Grauslund, Morten; Melchior, Linea Cecilie; Sørensen, Jens Benn; Santoni-Rugiu, Eric

Improvement of Diagnostics in NSCLC Patients with MET Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing Mutations

利用互补DNA/RNA-NGS技术改进MET外显子14突变NSCLC患者的诊断,并鉴定出两种新的外显子剪接突变

Urbanska, Edyta Maria; Doktor, Thomas Koed; Melchior, Linea Cecilie; Petersson, Eva Stampe; Sørensen, Jens Benn; Santoni-Rugiu, Eric; Andresen, Brage Storstein; Grauslund, Morten

Alectinib impressively enters the adjuvant setting for early-stage ALK-rearranged non-small cell lung cancer and outperforms chemotherapy-let's define who benefits the most

阿来替尼在早期ALK重排非小细胞肺癌的辅助治疗中表现出色,疗效优于化疗——让我们来探讨一下哪些患者获益最大。

Santoni-Rugiu, Eric; Sørensen, Jens Benn; Urbanska, Edyta Maria

Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 (+) or ALK (+) non-small cell lung cancer to crizotinib therapy.

靶向花生四烯酸调节的自噬以增强 ROS1 (+) 或 ALK (+) 非小细胞肺癌对克唑替尼治疗的敏感性

Jie Hui, Lai Hongjin, Wang Zihuai, Yi Min, Liu Yi, Urbanska Edyta Maria, Santoni-Rugiu Eric, Wei Shiyou, Chen Yuhao, Li Chuan, Wang Tengyong, Luo Nanzhi, Liu Lunxu, Deng Senyi, Guo Chenglin